PROCTER & GAMBLE HEALTH
|
The Current P/S Ratio of PROCTER & GAMBLE HEALTH is 7.50.
| Share Price | ₹5,802.9 | Dec 03,2025 |
| Market Cap | ₹9,632.7 Cr | |
| Sales-TTM | ₹1,284.4 Cr | TTM-Standalone Results |
| Price/Sales | 7.50x | Calculated as Market Cap/Sales |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PS (Price/Sales) ratio of PROCTER & GAMBLE HEALTH
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹9,632.7 Cr] as on Dec 03,2025
(/) Sales [ ₹1,284.4 Cr] based on TTM-Standalone Results
(=) P/S Ratio [ 7.50x ]
Thus, for PROCTER & GAMBLE HEALTH , the investors are currently willing to pay '7.50 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of PROCTER & GAMBLE HEALTH !
The chart below summarizes the trend in P/S Ratio of PROCTER & GAMBLE HEALTH over the last five years.
Historical PS (Price/Sales) ratio chart of PROCTER & GAMBLE HEALTH
PS Ratio Performance Analysis for PROCTER & GAMBLE HEALTH
- PROCTER & GAMBLE HEALTH 's p/e ratio for fiscal years ending Mar2025 to Jun2022 averaged 7.31x.
- PROCTER & GAMBLE HEALTH 's operated at median p/e ratio of 7.09x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, PROCTER & GAMBLE HEALTH 's p/e ratio peaked in Mar2025 at 9.14x.
- PROCTER & GAMBLE HEALTH 's p/e ratio hit its five-year low in Jun2022 of 6.24x.
How does PROCTER & GAMBLE HEALTH 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
|---|---|---|---|
| PROCTER & GAMBLE HEALTH | 1,284.4 | 7.50 | 9,632.7 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 54,964.0 | 7.88 | 433,248.0 |
| DIVIS LABORATORIES LTD | 10,029.0 | 17.08 | 171,344.0 |
| CIPLA LTD | 28,349.6 | 4.30 | 121,820.0 |
| TORRENT PHARMACEUTICALS LTD | 12,248.0 | 10.27 | 125,832.0 |
| DR REDDYS LABORATORIES LTD | 34,310.0 | 3.12 | 106,877.0 |
| MANKIND PHARMA LTD | 13,576.9 | 6.71 | 91,068.9 |
| ZYDUS LIFESCIENCES LTD | 24,493.9 | 3.84 | 94,173.4 |
| LUPIN LTD | 24,750.7 | 3.84 | 95,033.9 |
| AUROBINDO PHARMA LTD | 32,514.5 | 2.16 | 70,166.6 |
| ABBOTT INDIA LTD | 6,714.4 | 9.14 | 61,399.5 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs PROCTER & GAMBLE HEALTH 's P/S Ratio
| Top 10 Industry Peers | PS Ratio |
|---|---|
| Min industry PS | 2.16x |
| Max industry PS | 17.08x |
| Median industry PS | 6.71x |
| Average industry PS | 6.90x |
You may also like the below Video Courses